Mr. Amro Albanna reports

ADITXT TO HOST VIRTUAL STAKEHOLDER UPDATE AND Q&A SESSION ON FRIDAY, NOVEMBER 1, 2024, AT 11:30 AM EASTERN TIME

Appili Therapeutics Inc. will host an update and question-and-answer session with chief executive officer Amro Albanna this Friday, Nov. 1, 2024, at 11:30 a.m. ET. This update aims to connect with the company's stakeholders, including investors and the public, offering insights into Appili's latest developments and will address presubmitted questions.

This week's session will cover:

• Appili Therapeutics overview and transaction updates;

• Nasdaq compliance update;

• Q&A segment.

Participants are encouraged to engage directly by submitting questions via e-mail or video by Oct. 31, 2024, at 5 p.m. ET to engagement@aditxt.com.

About Appili Therapeutics Inc.

Appili Therapeutics is an innovation platform dedicated to accelerating promising health innovations. Appili's ecosystem of research institutions, industry partners and shareholders collaboratively drives its mission to "make promising innovations possible together." The innovation platform is the cornerstone of Appili's strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Appili operates a unique model that democratizes innovation, ensures every stakeholder's voice is heard and valued, and empowers collective progress.

We seek Safe Harbor.